# US 2015/0105266 A1 · Methods for selecting binders by phage display and masked selection

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0105266 A1
- Document ID: US20150105266A1
- Status: Published application
- Kind: A1
- Application number: 14/403,228
- Filed: 2013-05-24
- Published: 2015-04-16
- Earliest claimed: 2012-05-25
- Assignees: Inserm (Institut National De La Sante Et De La Recherche Medicale); Universite D'Aix-Marseille; Institut Jean Paoli & Irene Calmettes; Centre Natioanal De La Recherche Scientifique (Cnrs)
- Applicants: Inserm (Institut National De La Sante Et De La Recherche Medicale); Universite D'Aix Marseille; Institut Jean Paoli & Irene Calmettes; Centre Natioanal De La Recherche Scientifique (Cnrs)
- Inventors: Daniel Baty; Patrick Chames
- Web page: https://patentgrep.com/patent/US20150105266A1

## CPC

- C12N 15/1037: {Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display}
- C40B 30/04: by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C40B: COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES (in silico combinatorial libraries of nucleic acids, proteins or peptides G16B35/00; in silico combinatorial chemistry G16C20/60)

## Abstract

The present invention relates to methods for selecting binders by phage display and masked selection. More particularly, the present invention relates to a method for selecting a plurality of binders specific for at least one relevant target comprising screening a phage binder library of binders against the relevant target in presence of a plurality of binders obtained from a library of binders directed against at least one irrelevant target and positively selecting the binders that are specific for the at least one relevant target.

## Claims

### Claim 1

A method for selecting a plurality of binders specific for a relevant polypeptide comprising
i) building a binder library by using PBMCs obtained from at least one animal immunized with a fusion protein consisting of the relevant polypeptide fused to an irrelevant polypeptide
ii) producing a phage binder library by infecting the binder library of step i) with a helper phage
iii) performing with the phage binder library of step ii) at least one round of selection against the irrelevant polypeptide
iv) producing soluble binders with selected clones obtained at step iii)
v) performing with the phage binder library of step ii) at least one round of selection against the fusion protein of step i) in the presence of an excess of binders produced by step iv)
iv) cloning, recovering and optionally sequencing the binders from the clones selected at step v).

### Claim 2

A method for selecting a plurality of binders specific for a cell surface protein comprising
i) providing a cell that was genetically transformed so as to express at its surface the cell surface protein
ii) building a binder library by using PBMCs obtained from at least one animal immunized with the cell of step i)
iii) producing a phage binder library by infecting the binder library of step ii) with a helper phage
iv) performing with the phage binder library of step ii) at least one round of selection against the cell of step i) that was not genetically transformed
v) producing soluble binders with selected clones obtained at step iv)
vi) performing with the phage binder library of step iii) at least one round of selection against the cell of step i) in the presence of an excess of binders produced by step vi)
v) cloning, recovering and optionally sequencing the binders from the clones selected at step vi).

### Claim 3

A method for selecting a plurality of binders specific for a cell comprising
i) building a binder library by using PBMCs obtained from at least one animal immunized with the cell or a cell lysate
ii) producing a phage binder library by infecting the binder library of step i) with a helper phage
iii) performing with the phage binder library of step ii) at least one round of selection against a second cell or second cell lysate
iv) producing soluble binders with selected clones obtained at step iii)
v) performing with the phage binder library of step iv) at least one round of selection against the cell in the presence of an excess of binders produced by step iv)
vi) cloning, recovering and optionally sequencing the binders from the clones selected at step v).

### Claim 4

A method for selecting a plurality of binders with cancer specificity comprising
i) building a binder library by using PBMCs obtained from at least one animal immunized with a mixture of cancer biopsy lysates
ii) producing a phage binder library by infecting the binder library of step i) with a helper phage
iii) performing with the phage binder library of step ii) at least one round of selection against a mixture of normal biopsy lysate
iv) producing soluble binders with selected clones obtained at step iii)
v) performing with the phage binder library of step ii) at least one round of selection against the mixture of cancer biopsy lysates in the presence of an excess of binders produced by step iv)
vi) cloning, recovering and optionally sequencing the binders from the clones selected at step v).

### Claim 5

A method for selecting a plurality of binders with cancer specificity comprising
i) building a binder library by using PBMCs obtained from at least one animal immunized with a mixture of cancer cell lines
ii) producing a phage binder library by infecting the binder library of step i) with a helper phage
iii) performing with the phage binder library of step ii) at least one round of selection against a normal cell line
iv) producing soluble binders with selected clones obtained at step iii)
v) performing with the phage binder library of step ii) at least one round of selection against the mixture of cancer cell lines in the presence of an excess of binders produced by step iv)
vi) cloning, recovering and optionally sequencing the binders from the clones selected at step v).
